Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507024 · ClinicalTrials.gov registry record
The ANCA Vasculitis Questionnaire (AAV-PRO©)
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 280
- Enrollment target
NCT02507024: Completed study, sponsored by University of Pennsylvania.
NCT02507024 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 280 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02507024 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
Study Summary
The aim of this project is to develop a disease specific patient reported outcome measure (PROM) for patients with AAV (the AAV-PRO). Investigators are developing and validating a questionnaire to assess quality of life in patients with ANCA-associated vasculitis (AAV). Patients with AAV have inflammation in the small blood vessels leading to involvement of a range of organs and can suffer from ongoing disease activity or treatment side effects. Quality of life can be measured by patient reported outcome measures (PROMs).
Interventions
- OTHER Online questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02507024
The ClinicalTrials.gov registry entry for NCT02507024 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Online questionnaire is the first listed.
NCT02507024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02507024 about?
NCT02507024 is a clinical study titled "The ANCA Vasculitis Questionnaire (AAV-PRO©)". The aim of this project is to develop a disease specific patient reported outcome measure (PROM) for patients with AAV (the AAV-PRO). Investigators are developing and validating a questionnaire to assess quality of life in patients with ANCA-associated vasculitis (AAV). Patients with AAV have inflam...
What is the current status of trial NCT02507024?
This trial is currently completed. The enrollment target is 280 participants. The study started on 2015-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02507024?
The interventions under investigation include: Online questionnaire (OTHER).
Who is sponsoring clinical trial NCT02507024?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.